Early Session: Sensex gains 82 points | WeForNews | Latest News, Blogs Early Session: Sensex gains 82 points – WeForNews | Latest News, Blogs
Connect with us

Business

Early Session: Sensex gains 82 points

Published

on

bse-wefornews-wefornews

A benchmark index of Indian equities markets, the 30-scrip sensitive index (Sensex) of the BSE on Friday was trading 82.74 points, or 0.34 points, higher soon after the opening bell.

The wider 50-scrip Nifty of the National Stock Exchange (NSE) was also trading 20.45 points, or 0.27 percent, up at 7,533 points.

The Sensex, which opened at 24,729.41 points was trading at 24,760.11 points against the previous day’s close at 24,677.37 points.

The index touched a high of 24,778.98 points and a low of 24,729.21 points during the trade thus far.

Wefornews Bureau

Business

Patanjali chasing profits, exploiting people’s fear: Madras HC

Published

on

Baba Ramdev

Chennai, Aug 6 : Coming down heavily on yoga guru Ramdev’s Patanjali Ayurved Ltd for “chasing profits by exploiting people’s fear and panic” to sell its immunity booster tablet Coronil, the Madras High Court on Thursday slapped a penalty of Rs 10 lakh on it.

The court also refused to vacate the interim injunction restraining Patanjali from using the name Coronil for its tablet in a trade mark infringement case.

The case was filed by city-based company Arudra Engineers Private Ltd that had registered the trademarks “Coronil-92 B and Coronil-213 SPL” in 1993 and holds rights over them till 2027.

The company sells an anti-corrosion product – a chemical agent that undertakes to sanitise and clean heavy industrial machinery and containment units at factories.

Apart from Patanjali, the other defendant in the case was Divya Yog Mandir Trust that makes the tablet.

The court order came in the petition filed by Patanjali and Divya Yog to vacate the interim injunction against the use of the name Coronil for its tablet.

The court said: “Insofar as costs are concerned, the defendants have repeatedly projected that they are Rs 10,000 crore company. However, they are still chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus, when actually their ‘Coronil Tablet’ is not a cure but rather an immunity booster for cough, cold and fever.”

“The defendants must realize that there are organisations which are helping the people in this critical period without seeking recognition and it would only be appropriate that they are made to pay costs to them,” it ruled.

The court ordered Patanjali and Divya Yog to pay jointly Rs 5 lakh each to the Dean, Adyar Cancer Institute, Chennai and to the Dean, Government Yoga and Naturopathy Medical College & Hospital, Chennai.

In both the organisations, treatment are accorded free of cost without any claim to either trademark, trade name, patent or design, but only with service as a motto, the court said.

“Costs to be paid on or before 21.08.2020, and a memo in this regard, to be filed before the Registry, High Court Madras, on or before 25.08.2020,” it ordered.

Continue Reading

Business

Q1FY21 results: Vodafone Idea loss widens by 422.37 per cent YoY to Rs 25,460 crore

Average Revenue per User (ARPU) dropped to Rs 114 in Q1FY21 as against Rs 121 in Q4FY20.

Published

on

Vodafone, Idea

Vodafone Idea Ltd. announced its quarterly results on Thursday post market hours. The company posted a consolidated net loss of Rs 25,460 crore for Q1FY21, which increased by 422.37 per cent, as compared to Q1FY20 when it reported a consolidated loss of Rs 4873.9 crore.

The consolidated net sales reported in Q1FY21 came in at Rs 10,659.3 crore, which declined by 5.42 per cent YoY from Rs 11,269.9 crore in Q1FY20. At EBITDA level, the company stood at Rs 4,098.4 crore in Q1FY21 that increased by 10.28 per cent YoY. For Q1FY20, it posted an EBITDA of Rs 3,716.3 crore.

EBITDA margin as of Q1FY21 was at 38.45 per cent that increased by 5.47 per cent YoY. The net profit margin in Q1FY21 came in at -238.85 per cent, which declined by 195.60 per cent YoY. The net profit margin in Q1FY20 was at -43.25 per cent.

The company recorded exceptional cost of Rs 19,923.2 crore which includes merger related cost, licence fee, spectrum usage charges (SUC) on adjusted gross revenue (AGR).

Average Revenue per User (ARPU) dropped to Rs 114 in Q1FY21 as against Rs 121 in Q4FY20.

Q1FY21 was turned out to be a challenging quarter for the company as availability of recharges due to store closure due to lockdown and ability of customers to recharge on account of economic slowdown were affected.

The share closed with drop of 0.72 per cent at Rs 8.25 on BSE.

Continue Reading

Business

Real GDP growth to remain negative in H1, full fiscal: RBI Gov Shaktikanta Das

RBI MPC meet: More protracted spread of the pandemic, deviations from the forecast of a normal monsoon, and global financial market volatility are the key downside risks, said Das

Published

on

National debt under Modi govt surges
  • Covid-19 impact: India’s GDP to contract 6.1% in FY21, says Nomura
  • Coronavirus crisis: Banks should raise capital proactively, says RBI Governor Shaktikanta Das
  • Rising real lending rates causing steep slump in credit flows, GDP

Reserve Bank of India Governor Shaktikanta Das said that the real GDP growth of the country is expected to remain in the contraction zone. “Real GDP in the first half of the year is expected to remain in the contraction zone.

For the year 2021 as a whole real GDP growth is also estimated to be negative,” said Governor Das during the MPC presser on Thursday.

Das said that in case of an early containment of the COVID-19 spread, there could be an upside to the outlook. “More protracted spread of the pandemic, deviations from the forecast of a normal monsoon, and global financial market volatility are the key downside risks,” he added.

“As regards the outlook for growth, the MPC noted that the recovery of the rural economy is expected to be robust, buoyed by the progress in kharif sowing. Manufacturing firms expect domestic demand to recover gradually from Q2 and to sustain through Q1 2021-22. On the other hand, consumer confidence turned more pessimistic in July relative to the preceding round of the Reserve Bank’s survey. External demand is expected to remain anaemic under the weight of the global recession and 5 contractions in global trade,” Das stated.

He said that the MPC has noted that in such an environment of unprecedented stress, supporting recovery of the economy would assume primacy in the conduct of the monetary policy. “While the space for further monetary policy is available, it is important to use it judiciously to maximise the beneficial effects on the underlying economy,” Das highlighted.

Das said there were signs of recovery across the world. “Monetary Policy Committee noted that in India too, economic activity had started to recover, but surges of fresh infections have forced fresh lockdowns, hence several high-frequency indicators have levelled off,” he added.

Additionally, the MPC putting all debates to rest, left the repo rate unchanged at 4 per cent and would maintain an accommodative stance.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.